If androgen withdrawal in prostate cancer treatment decreases anti-apoptotic gene expression as DcR2 in androgen-dependent cells, this could induce apoptosis, resulting in prostate tumour reduction. The gene discussed is TNFRSF10D; the disease is prostate neoplasm.